Literature DB >> 26876241

Adverse effects of a 10-day course of ibuprofen in Holstein calves.

P Walsh1,2,3, F R Carvallo Chaigneau4, M Anderson5, N Behrens3, H McEligot3, B Gunnarson3, L J Gershwin3.   

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are recommended for various conditions in cattle. Ibuprofen is an inexpensive short-acting NSAID and is readily available in liquid formulation for administration to bottle-fed calves. We compared the adverse effects of a 10-day course of ibuprofen and placebo in 16 five- to six-week-old Holstein bull calves that were being treated for experimentally induced bovine respiratory syncytial virus infection. Ibuprofen was administered as a liquid in milk replacer at 30 mg/kg divided three times daily. We found an increased prevalence of abomasal ulceration 5 of 8 in the ibuprofen compared to placebo group 2 of 6 (P = NS). There was one (1 of 8) case of mild interstitial nephritis in the ibuprofen and none (0 of 8) in the placebo group (P = NS). Renal function as measured by serum BUN and creatinine levels was not different between groups; no animal demonstrated an increase in creatinine.
© 2016 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26876241      PMCID: PMC4983537          DOI: 10.1111/jvp.12295

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  22 in total

1.  Efficacy of ketoprofen administered in drinking water at a low dose for the treatment of porcine respiratory disease complex.

Authors:  M Salichs; D Sabaté; J Homedes
Journal:  J Anim Sci       Date:  2013-07-03       Impact factor: 3.159

2.  Effect of clenbuterol on the incidence of abomasal ulcers in veal calves.

Authors:  H J Breukink; T Wensing; S van Dijk; D Mevius
Journal:  Vet Rec       Date:  1989-07-29       Impact factor: 2.695

3.  Ibuprofen treatment of endotoxin-induced mastitis in cows.

Authors:  F J DeGraves; K L Anderson
Journal:  Am J Vet Res       Date:  1993-07       Impact factor: 1.156

4.  Pharmacokinetics of ibuprofen in lactating dairy cows.

Authors:  F J DeGraves; K L Anderson; D P Aucoin
Journal:  Am J Vet Res       Date:  1993-07       Impact factor: 1.156

5.  The importance of adverse reaction reporting by physicians. Suprofen and the flank pain syndrome.

Authors:  A C Rossi; L Bosco; G A Faich; A Tanner; R Temple
Journal:  JAMA       Date:  1988-02-26       Impact factor: 56.272

6.  Clinical efficacy of flunixin, carprofen and ketoprofen as adjuncts to the antibacterial treatment of bovine respiratory disease.

Authors:  P W Lockwood; J C Johnson; T L Katz
Journal:  Vet Rec       Date:  2003-03-29       Impact factor: 2.695

7.  Abattoir survey of bovine kidney disease.

Authors:  M L Monaghan; J Hannan
Journal:  Vet Rec       Date:  1983-07-16       Impact factor: 2.695

8.  A survey of abomasal ulceration in veal calves.

Authors:  D D Welchman; G N Baust
Journal:  Vet Rec       Date:  1987 Dec 19-26       Impact factor: 2.695

9.  Effect of surgical castration with or without oral meloxicam on the acute inflammatory response in yearling beef bulls.

Authors:  S L Roberts; H D Hughes; N C Burdick Sanchez; J A Carroll; J G Powell; D S Hubbell; J T Richeson
Journal:  J Anim Sci       Date:  2015-08       Impact factor: 3.159

10.  Safety profile of ibuprofen suspension in young children.

Authors:  E Ashraf; L Ford; R Geetha; S Cooper
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 5.093

View more
  2 in total

1.  A randomized controlled trial of a combination of antiviral and nonsteroidal anti-inflammatory treatment in a bovine model of respiratory syncytial virus infection.

Authors:  Paul Walsh; Maxim Lebedev; Heather McEligot; Victoria Mutua; Heejung Bang; Laurel J Gershwin
Journal:  PLoS One       Date:  2020-03-12       Impact factor: 3.240

2.  A Randomized Placebo Controlled Trial of Ibuprofen for Respiratory Syncytial Virus Infection in a Bovine Model.

Authors:  Paul Walsh; Nicole Behrens; Francisco R Carvallo Chaigneau; Heather McEligot; Karan Agrawal; John W Newman; Mark Anderson; Laurel J Gershwin
Journal:  PLoS One       Date:  2016-04-13       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.